Suppr超能文献

在双目间接检眼镜检查中降低散瞳剂不良反应的风险

Minimizing risk of adverse reactions to mydriatic agents in binocular indirect ophthalmoscopy.

作者信息

Levine L

出版信息

J Am Optom Assoc. 1985 Jul;56(7):542-8.

PMID:4020007
Abstract

To minimize the risk of adverse side effects from mydriatics during binocular indirect ophthalmoscopy, a procedure was developed which intentionally starts with a dose significantly less than an ED99. Using a clinically effective diameter of greater than 7 mm as a criterion, I found that 1 drop of 0.5% tropicamide (T) constituted an ED74 (N = 46). When 1 drop of 2.5% phenylephrine (P) was added, this increased to an ED93 (N = 27). If present results can be generalized, then 1 drop of T, supplemented at 30 minutes with 1 drop of P, if necessary, should produce satisfactory dilatation in approximately 90% of the subjects.

摘要

为了将双目间接检眼镜检查期间使用散瞳剂产生副作用的风险降至最低,我们开发了一种程序,该程序有意从显著低于ED99的剂量开始。以大于7mm的临床有效直径为标准,我发现1滴0.5%托吡卡胺(T)构成ED74(N = 46)。当添加1滴2.5%去氧肾上腺素(P)时,这增加到ED93(N = 27)。如果目前的结果可以推广,那么1滴T,如果必要的话,在30分钟后补充1滴P,应该能在大约90%的受试者中产生令人满意的散瞳效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验